Report overview
A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occur in men and women of all ages.
This report contains market size and forecasts of Migraine With Brainstem Aura Drugs in Global, including the following market information:
Global Migraine With Brainstem Aura Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Migraine With Brainstem Aura Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Abortive Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Migraine With Brainstem Aura Drugs include Pfizer, GlaxoSmithKline, Abbott Laboratories, Eli Lily, Johnson & Johnson, AstraZeneca, Eisai, Allergen and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Migraine With Brainstem Aura Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine With Brainstem Aura Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, by Type, 2021 (%)
Abortive Medication
Preventive Medication
Global Migraine With Brainstem Aura Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Others
Global Migraine With Brainstem Aura Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Migraine With Brainstem Aura Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Migraine With Brainstem Aura Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GlaxoSmithKline
Abbott Laboratories
Eli Lily
Johnson & Johnson
AstraZeneca
Eisai
Allergen
Merck
Endo International
Impax Laboratories
